Satara Co-operative Group says EastPack has backed out of the proposed merger between the two companiesbecause of the bacterial infection spreading through the nation's kiwifruit orchards.
"EastPack has indicated that its decision is due to significant commercial uncertainty it believes the recent Psa bacteria outbreak has had on its orchardsand the industry in general, and the associated impact on the availability and pricing of capital from their banking provider to fund the merger," Satara told the NZX.
Satara, which is listed on the alternative index, announced in September that it was looking to merge with EastPack to form a wholly grower-owned company.
Since the disease incursion, Satara directors had unsuccessfully sought to renegotiate merger terms.
They said with a recent unconditional agreement to sell a surplus property in Mt Maunganui, Satara was confident of the relative strength of its balance sheet. "Satara continues to consider that the potential impact of Psa on its 2011 crop supply will be minimal."
The companies last month put the merger vote on hold as the companies renegotiated the price and deal structure.
The kiwifruit industry and taxpayers are jointly funding a $50 million compensation package to manage Psa, but the costs of the battle against the bacteria have been estimated at $75 million, with growers expected to fund most of the additional amount.
Satara said the bacteria had had a minimal impact on its crop, despite three of its orchards testing positive for Psa, and it did not expect a significant effect on its supply.
Psa became a serious problem in Zespri's Hort16A (gold kiwifruit) and the Jin Tao cultivar in Italy during the last season. In April, Opotiki-based post-harvest group Opac announced it might have to write off its NewGold orchard there. Satara has a 20 per cent stake in Opac.
Before the disease incursion was discovered, EastPack chairman Ray Sharp said EastPack and Satara were two like-minded co-operatives.
